The 21st century will be marked by the convergence of artificial intelligence, fuelled by Moore's Law ('Mursla' pronounced in Japanese), and the increasing ability to decode the complex language of biology ('Bio')
Leadership
Experienced biotech entrepreneur in both liquid biopsy and extracellular vesicle (EV) fields
A decade of experience in healthcare investment banking at J.P. Morgan
Multiple patents and publications in EV biomedical applications
Closed over 20 transactions valued $70B
Postgraduate research in biophysics and nanoelectronics at the University of Cambridge (Cavendish Laboratory)
Received his Master of Science in Management from HEC Paris (Grande Ecole)
Pierre Arsène
Founder & CEO
Over a decade of scientific experience in the liquid biopsy space, including EV-based diagnostics
Many scientific publications and inventions in the fields of cfDNA, EVs, biochips, microfluids and automation
Pioneering EV research at MD Anderson Cancer Center – Kalluri Lab
Received his Ph.D in Bioengineering Systems from MIT – Portugal Programme
Received his MSc in Bioengineering and Nanosystems from the Instituto Superior Technico
Tomás Dias, PhD
Chief SCIENTIFIC Officer
Over 25 years in various life science leadership positions in both the US and the UK
Brought >20 innovative products to market from R&D to launch, including in vitro diagnostics (IVD) tests
Led 40-centre UK-based clinical trial and 20-centre US observational study
Received her Ph.D. in Molecular Biology from the University of Southern Carolina
Post doctoral research in genetics at the University of Cambridge
Karin Schmitt, PhD
Chief Operating Officer
Advisors
20 years of experience in automatising liquid biopsy solutions, including for cfDNA, proteins and EVs
COO and CTO at Chemify, and previous work experience at Xilis, Guardant Health and Freenome
Received his Ph.D. in biomedical engineering from Carnegie Mellon University
Daniel Delubac, PhD
Liquid biopsy expert
Global scientific leader on EV biomedical applications
Professor in Translational EV Research at the University of Duisburg-Essen
Over 100 publications about EVs including single EV characterisation
Received his Ph.D. in neurogenesis at the University of Cologne
Bernd Giebel, PhD
Extracellular vesicle expert
Leading research group dedicated to the study of the role of vessels in liver disease as well as the role of EVs
Professor of Hepatology at the University of Paris
Received his Ph.D. in vascular biology and MD at the University of Paris 7
PE Rautou, MD PhD
LIVER DISEASE expert
Leading the translational research program at Imperial College London
Awarded a Wellcome Trust Strategic Fund Clinician Scientist fellowship in immunotherapy for hepatocellular carcinoma
Received his Ph.D. in Clinical and Experimental Medicine at the University of Piemontale
David Pinato, MD PhD
Liver oncology expert
Assistant Professor in the Department of Urology at Mayo Clinic
Board member of Blood Task Force at ISEV
Received his Ph.D. in Immunology from the University of Sherbrooke
